Surveillance of screening for hepatitis C through the laboratory network RENA-VHC, France, 2000-2001

C Meffre; C Larsen; A Perin; L Bouraoui; E Delarocque Astagneau

doi:10.2807/esm.08.05.00410-en

Surveillance report Open Access

Like 0

This item has no PDF Download

Surveillance of screening for hepatitis C through the laboratory network RENA-VHC, France, 2000-2001
C Meffre¹ , C Larsen¹ , A Perin¹ , L Bouraoui¹ , E Delarocque Astagneau¹
View Affiliations Hide Affiliations

Affiliations: ¹ Infectious Disease Department, National public health institute, Saint-Maurice, France

Correspondence:
View Citation Hide Citation

Citation style for this article: Meffre C, Larsen C, Perin A, Bouraoui L, Delarocque Astagneau E. Surveillance of screening for hepatitis C through the laboratory network RENA-VHC, France, 2000-2001. Euro Surveill. 2003;8(5):pii=410. https://doi.org/10.2807/esm.08.05.00410-en

Abstract

Over the period 2000-2001, 189 private or hospital laboratories scattered throughout France participated to the laboratory network RENA-VHC. A total of 759 591 serologies (screening tests and validation of screening tests) were performed, revealing an increase of 10% between 2000 and 2001. The rate of the amount of tests to validate screening found positive over the overall amount of tests performed was 1.2% in 2000 and 1.0% in 2001. This suggests that screening covered more people with little risk of acquiring HCV infection. The per-sons confirmed HCV positive were predominantly men (sex ratio 1.5) of which 31% were30 to 39 years of age.